ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "Sunesis Pharmaceuticals, Inc." (SNSS) Report Updated: Sep 16, 2017 | Print This Page

Get more stock ratings by Louis Navellier

"Sunesis Pharmaceuticals, Inc." (SNSS)

Rating: Sell Volatility: Moderate
Total Grade: D Industry: Biotechnology
Competitors: SMMT,CYAD,KITE,CALA

Stock Analysis

Rating: Monthly View

A
B
C
D
F
September October November December January February March April May June July August

Rating: Weekly View

This Week: D down no change
Last Week: D same no change
Two Weeks Ago: D up no change
service keys

"Sunesis Pharmaceuticals, Inc."© quotemedia

Company Profile